N Sakaki Selected Research

1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamine

1/2017

Randomised clinical trial: efficacy and safety of vonoprazan vs. lansoprazole in patients with gastric or duodenal ulcers - results from two phase 3, non-inferiority randomised controlled trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N Sakaki Research Topics

Disease

2	Duodenal Ulcer (Curling's Ulcer) 01/2017 - 01/2000
2	Stomach Ulcer (Gastric Ulcer) 01/2017 - 01/2000
1	Atrophy 04/2002
1	Brain Death (Brain Dead) 12/2001
1	Sclerosing Cholangitis 12/2001
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 12/2001
1	Atrophic Gastritis 02/2001
1	Metaplasia 02/2001
1	Infections 02/2001
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2001
1	Peptic Ulcer (Peptic Ulcers) 01/2000

Drug/Important Bio-Agent (IBA)

2	Lansoprazole (Prevacid)FDA LinkGeneric 01/2017 - 01/2000
2	Proton Pump InhibitorsIBA 01/2017 - 01/2000
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 01/2017
1	Inosine Triphosphate (ITP)IBA 12/2001
1	Coloring Agents (Dyes)IBA 02/2001
1	Methylene Blue (Methylthioninium Chloride)FDA Link 02/2001
1	AutoantibodiesIBA 01/2001

Therapy/Procedure

2	Therapeutics 02/2001 - 01/2000
1	Aftercare (After-Treatment) 04/2002
1	Splenectomy 12/2001
1	Liver Transplantation 12/2001